Exhibition CPhI Worldwide 2018 Madrid
From 09 to 11 October 2018, the company JLLC «Lekpharm» takes part in the world exhibition CPhI Worldwide in Madrid, Spain
Seminar «New production capabilities of the pharmaceutical company JLLC «Lekpharm»
On September 25 and October 2, 2018, the pharmaceutical workers of Belparmacia RUE and Mogilev Pharmacy RUE took part in the training seminar «New production capabilities of the pharmaceutical company JLLC «Lekpharm».
In 2018, the trade name of the drug Nifuroxazide-LF was changed
С 3 квартала 2018 года лекарственное средство в обеих дозировках 100 и 200 мг можно купить в аптеках под новым торговым названием - Нифурокс.
Updating the fleet «Lekpharm» JLLC
In 2018, two new IVECO refrigerator trucks (35С15 and 70С15) were purchased
Lozartan Plus - winner of the tender for all dosages
In May and June 2018, the medicinal product Lozartan Plus LLC Lefpharm was awarded procurement contracts of the Republic of Belarus for all three dosages
JLLC «Lekpharm» on the Republican Board of Honor
For the achievement of the best indicators in the sphere of social and economic development among the organizations of industry in 2017, JLLC «Lekpharm» is listed on the Republican Board of Honor!
New drugs JLLC «Lekpharm»
Since the 1st quarter of 2018 JLLC «Lekpharm» implements new registered drugs
A new class of antihypertensive drugs from JLLC «Lekpharm»
In the first half of 2018 JLLC «Lekpharm» expanded the capabilities of doctors in the treatment of patients with cardiovascular diseases, mastering the release of drugs from the new class - antagonists of angiotensin II receptors (sartans)
Release of the third dosage in the line of the new drug - Bicard AM (bisoprolol / amlodipine)
JLLC «Lekpharm» informs health professionals about the release of the third dosage in the line of the new drug - Bicard AM (bisoprolol / amlodipine). The company mastered the release of tablets 5 mg / 10 mg № 30.